InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
20%
T+90 mean return
-11.1%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by GAROFALO ELIZABETH A., Director. Director active across 3 companies, notably Acadia Pharmaceuticals INC. Cumulatively, 14 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €84k. Activity tracked since 16 June 2022. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
28,700 sharesCommon StockSEC:0001193125-26-274132:0
8,107 sharesCommon StockSEC:0001826361-26-000002:0
28,700 shares0Common StockSEC:0000950170-25-085618:0
9,387 sharesCommon StockSEC:0001415889-25-015272:0
4,919 shares@ US$18.23100.0% of flowCommon StockSEC:0001415889-25-007299:0
35,000 shares0Common StockSEC:0000950170-24-072516:0
6,652 sharesCommon StockSEC:0001415889-24-015088:0
3,500 shares@ US$18.56100.0% of flowCommon SharesSEC:0000950170-24-029542:0
9,459 shares0Common StockSEC:0000950170-23-068620:0
2,918 shares0Common StockSEC:0001209191-23-056827:0
26,250 shares0Common StockSEC:0000950170-23-028267:0
6,391 sharesCommon StockSEC:0001209191-23-034694:0
9,459 shares0Common StockSEC:0001209191-22-038536:0
1,918 sharesCommon StockSEC:0001209191-21-058556:0
14 of 14 declarations
About GAROFALO ELIZABETH A.
Elizabeth A. Garofalo is a Director at Acadia Pharmaceuticals Inc. and Alector, Inc. She brings her expertise and experience to the board, contributing to the strategy and governance of these companies. Her role is crucial for ensuring the growth and sustainability of Acadia Pharmaceuticals Inc. and Alector, Inc.
